| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.05 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |